136 related articles for article (PubMed ID: 1370451)
21. Glycosaminoglycans inhibit formation of the 140 kDa insulin-like growth factor-binding protein complex.
Baxter RC
Biochem J; 1990 Nov; 271(3):773-7. PubMed ID: 1700901
[TBL] [Abstract][Full Text] [Related]
22. Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia.
Baxter RC; Holman SR; Corbould A; Stranks S; Ho PJ; Braund W
J Clin Endocrinol Metab; 1995 Sep; 80(9):2700-8. PubMed ID: 7545698
[TBL] [Abstract][Full Text] [Related]
23. [The structural organization of binding determinants in insulin-like growth factor-I (IGF-I) molecule].
Kolychev AP
Zh Evol Biokhim Fiziol; 2010; 46(1):74-94. PubMed ID: 20297673
[TBL] [Abstract][Full Text] [Related]
24. A purified bovine serum albumin preparation contains an insulin-like growth factor (IGF) binding protein-3 fragment that forms ternary complexes selectively with IGF-II and the acid-labile subunit.
Twigg SM; Hardman KV; Baxter RC
Growth Horm IGF Res; 2000 Aug; 10(4):215-23. PubMed ID: 11032705
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the high molecular weight insulin-like growth factor complex in term pregnancy serum.
Liu F; Baxter RC; Hintz RL
J Clin Endocrinol Metab; 1992 Nov; 75(5):1261-7. PubMed ID: 1385469
[TBL] [Abstract][Full Text] [Related]
26. Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes.
Arai T; Parker A; Busby W; Clemmons DR
J Biol Chem; 1994 Aug; 269(32):20388-93. PubMed ID: 7519608
[TBL] [Abstract][Full Text] [Related]
27. Altered ligand specificity of proteolysed insulin-like growth factor binding protein-3.
Baxter RC; Skriver L
Biochem Biophys Res Commun; 1993 Nov; 196(3):1267-73. PubMed ID: 7504473
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor (IGF) binding protein-3 in pregnancy serum binds native IGF-I but not iodo-IGF-I.
Suikkari AM; Baxter RC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1377-9. PubMed ID: 1720128
[TBL] [Abstract][Full Text] [Related]
29. Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation.
Yan X; Forbes BE; McNeil KA; Baxter RC; Firth SM
J Biol Chem; 2004 Dec; 279(51):53232-40. PubMed ID: 15485880
[TBL] [Abstract][Full Text] [Related]
30. N-Linked glycosylation and sialylation of the acid-labile subunit. Role in complex formation with insulin-like growth factor (IGF)-binding protein-3 and the IGFs.
Janosi JB; Firth SM; Bond JJ; Baxter RC; Delhanty PJ
J Biol Chem; 1999 Feb; 274(9):5292-8. PubMed ID: 10026136
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor binding protein-3: factors affecting binary and ternary complex formation.
Holman SR; Baxter RC
Growth Regul; 1996 Mar; 6(1):42-7. PubMed ID: 8717449
[TBL] [Abstract][Full Text] [Related]
32. Localization of the epitope of a monoclonal antibody against human insulin-like growth factor binding protein-1, functionally interfering with insulin-like growth factor binding.
Schuller AG; Lindenbergh-Kortleve DJ; de Boer WI; Zwarthoff EC; Drop SL
Growth Regul; 1993 Mar; 3(1):32-4. PubMed ID: 7683523
[TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor I and its binding proteins in the experimental nephrotic syndrome.
Hirschberg R; Kaysen GA
Endocrinology; 1995 Apr; 136(4):1565-71. PubMed ID: 7534704
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factors (IGFs) and IGF binding proteins, serum acid-labile subunit and growth hormone binding protein in nephrotic children.
Haffner D; Tönshoff B; Blum WF; Vickers M; Siebler T; Cronin MJ; Baxter RC; Mehls O
Kidney Int; 1997 Sep; 52(3):802-10. PubMed ID: 9291202
[TBL] [Abstract][Full Text] [Related]
35. Effects of insulin-like growth factor I treatment on the molecular distribution of insulin-like growth factors among different binding proteins.
Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Diamond FB; Baxter RC; Rosenbloom AL; Guevara-Aguirre J; Rosenfeld RG
Acta Paediatr Suppl; 1994 Apr; 399():159-62. PubMed ID: 7524822
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.
Bang P; Degerblad M; Thorén M; Schwander J; Blum W; Hall K
Acta Endocrinol (Copenh); 1993 May; 128(5):397-404. PubMed ID: 7686320
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of the acid-labile subunit of the growth-hormone-dependent insulin-like-growth-factor-binding protein complex by rat hepatocytes in culture.
Scott CD; Baxter RC
Biochem J; 1991 Apr; 275 ( Pt 2)(Pt 2):441-6. PubMed ID: 1709006
[TBL] [Abstract][Full Text] [Related]
38. Basic fibroblast growth factor regulates IGF-I binding proteins in the clonal osteoblastic cell line MC3T3-E1.
Hurley MM; Abreu C; Hakeda Y
J Bone Miner Res; 1995 Feb; 10(2):222-30. PubMed ID: 7538725
[TBL] [Abstract][Full Text] [Related]
39. Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast.
Kiefer MC; Schmid C; Waldvogel M; Schläpfer I; Futo E; Masiarz FR; Green K; Barr PJ; Zapf J
J Biol Chem; 1992 Jun; 267(18):12692-9. PubMed ID: 1377672
[TBL] [Abstract][Full Text] [Related]
40. Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling.
Baxter RC; Martin JL
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):6898-902. PubMed ID: 2476804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
